Main > OPHTHALMOLOGY > USA. A. Glaucoma>Treat.> ** > >Single Compound Therapy>



>Single Compound Therapy>'s subsections
(*) USA Approval Date: 2017. 12.18.
(*) USA Launch Date: 2018. 04.
>Netarsudil Ophthalmic Solution
Company
Patent>Assignee; Claims; No.; Etc.
Patent>Total USA No.: 4
Patent>UpDate: 2018. 03.12.
TradeMark
TradeMark Web-Site

>Single Compound Therapy>'s products
This section has no products